// App-Quantinova.ai

481 : An affinity-optimized CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade

Researchers

Presenter

  • Xavier Chauchet

Principal Investigators

  • Margaux Legrand

  • Laura Cons

  • Laurence Chatel

  • Adeline Lesnier

  • Nicolas Bosson

  • Pauline Lloveras

  • Pauline Malinge

  • Ulla Ravn

  • Valery Moine

  • Bruno Daubeuf

  • Yves Poitevin

  • Giovanni Magistrelli

  • Susana Salgado-Pires

  • Dmitry Shchelokov

  • Oleg Demin

  • Limin Shang

  • Krzysztof Masternak

  • Walter Ferlin

Medical Centers

  • InsysBio UK Ltd, Edinburgh, UK

  • Light Chain Bioscience-Novimmune SA, Geneva, Switzerland

Locations

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved